Strategic Forecast for the Antibody Discovery Industry: Market Outlook 2025-2034

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

Antibody Discovery Market Size Growth Forecast: What to Expect by 2025?
The market size for antibody discovery has seen substantial growth in recent times, expanding from $8.96 billion in 2024 to an estimated $9.78 billion in 2025, with a Compound Annual Growth Rate (CAGR) of 9.2%. The historical period's growth is credited to a significant increase in investment for drug discovery, an uptick in research and development activities funding, coupled with the existence of numerous healthcare research centers and academic institutions.

How Will the Antibody Discovery Market Size Evolve and Grow by 2029?
In the coming years, the antibody discovery market is predicted to witness substantial growth, expanding to $14.31 billion in 2029 with a Compound Annual Growth Rate (CAGR) of 10.0%. This predicted growth for the forecast period can be credited to the rise in demand for antibody drug discovery services and platforms, an increase in funding for the development of innovative technologies, a growing need for precision therapeutics, and an increase in the usage of antibodies beyond their traditional therapeutic functions. Key trends in the forecast period include heightened research and development activities, an increased demand for monoclonal antibodies, higher adoption of cutting-edge technologies, growing demand for targeted therapeutics, and the creation of new antibody formats.

View the full report here:
https://www.thebusinessresearchcompany.com/report/antibody-discovery-global-market-report

What Drivers Are Propelling the Growth of Antibody Discovery Market Forward?
The burgeoning demand for precision or personalized medical treatments is seen as a force that will metamorphose and expedite the expansion of the antibody discovery field. Personalized therapeutics simply hint at the process of tailoring medical treatment to the distinct features of each patient. The discovery of antibodies plays a pivotal role in this area, leading to the production of target-oriented therapies like monoclonal antibodies. These therapies are devised to specifically associate with disease-related molecules or cells, ensuring more impactful and customized treatment solutions. For example, in January 2023, the US-based Personalized Medicine Coalition, a professional member organization, revealed that the FDA's Center for Drug Evaluation and Research (CDER) approved 37 fresh molecular entities (NMEs) in 2022. Out of these, nearly 34%, equating to 12 NMEs, were classified as personalized medicines by the Personalized Medicine Coalition (PMC). Hence, the escalating demand for precision therapeutics is anticipated to fuel the growth of the antibody discovery market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=13783&type=smp

What Are the Key Trends Driving Antibody Discovery Market Growth?
Prominent businesses in the antibody discovery market are creating cutting-edge technologies, including AI-powered computational antibody drug discovery platforms, to enhance the effectiveness and accuracy of antibody creation. This kind of platform leverages artificial intelligence and computational methodologies to speed up the detection and optimization of therapeutic antibodies. For example, SwiftPharma BV, a Belgian company that creates recombinant proteins from a distinctive plant-based system, launched an AI-guided antibody discovery platform in October 2023. This revolutionary system merges artificial intelligence, massive data, machine learning, and phage display technologies to quickly forecast high-specificity and high-affinity antibody-antigen linkage. The method, similar to natural language processing, produces a variety of antibody alterations, making it easier for SwiftPharma to create extensive antibody libraries. This state-of-the-art system speeds up the uncovering of potential antibody drugs at an unmatched pace.

What Are the Key Segments in the Antibody Discovery Market?
The antibody discovery market covered in this report is segmented -

1) By Methods: Phage Display, Hybridoma, Other Methods
2) By Antibody Type: Humanized Antibody, Human Antibody, Chimeric Antibody, Murine Antibody
3) By End Users: Pharmaceutical And Biotechnology Industry, Research Laboratory, Academic Laboratory

Subsegments:
1) By Phage Display: Selection And Screening Techniques, Optimization Methods
2) By Hybridoma: Monoclonal Antibody Production, Screening And Selection Processes
3) By Other Methods: Transgenic Mouse Technology, B-Cell Engineering, Single-Cell Sorting Techniques

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=13783&type=smp

Who Are the Key Players Shaping the Antibody Discovery Market's Competitive Landscape?
Major companies operating in the antibody discovery market report are Danaher Corporation, Eurofins Scientific, Sartorius AG, Charles River Laboratories, Bruker Corporation, WuXi Biologics, Genmab A/S, Evotec, Cambrex corporation, ChemPartner, Aragen life science Pvt ltd, Genscript Technology Corporation, Biocytogen, Alcami Corporation Inc, Twist Bioscience, BioDuro-Sundia, Fairjourney Biologics S.A, Harbour BioMed, Rockland Immunochemicals, Creative Biolabs, Synbio technologies, ImmunoPrecise, Ablexis, Myrio Therapeutics, Antibody Solutions, MabSilico

What Geographic Markets Are Powering Growth in the Antibody Discovery Market?
North America was the largest region in the antibody discovery market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the antibody discovery market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=13783

This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Saumya Sahey
Europe: +44 7882 955267,
Asia: +44 7882 955267 & +91 8897263534,
Americas: +1 310-496-7795
Email: saumyas@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.